HEMISPHERX BIOPHARMA INC Uncategorized Contracts & Agreements

65 Contracts & Agreements
Recent Contracts
Category
Company
Industry
Jur. Jurisdiction
Filed
Form of Lock-up Agreement
HEMISPHERX BIOPHARMA INC
Biotechnology
2025
Amended and Restated Material Transfer and Research Agreement with Roswell Park Cancer Institute Corporation
HEMISPHERX BIOPHARMA INC
Biotechnology
NY
2023
Material Transfer and Research Agreement, dated as of May 22, 2023, by and between AIM ImmunoTech Inc. and Japanese National Institute of Infectious Disease. (portions of this...
HEMISPHERX BIOPHARMA INC
Biotechnology
NY
2023
Unrestricted Grant Agreement with Erasmus University Medical Center
HEMISPHERX BIOPHARMA INC
Biotechnology
2023
March 1, 2023 Extension Agreement with Foresite Advisors LLC
HEMISPHERX BIOPHARMA INC
Biotechnology
2023
January 13, 2023 Co-ordination Agreement with Erasmus University Medical Center Rotterdam and AstraZeneca BV (portions of this agreement have been redacted in compliance with...
HEMISPHERX BIOPHARMA INC
Biotechnology
2023
January 13, 2023 Study Support Agreement with Erasmus University Medical Center Rotterdam (portions of this agreement have been redacted in compliance with Regulation S-K Item...
HEMISPHERX BIOPHARMA INC
Biotechnology
2023
October 21, 2022 Material Transfer and Research Agreement with University of Pittsburgh (portions of this agreement have been redacted in compliance with Regulation S-K Item...
HEMISPHERX BIOPHARMA INC
Biotechnology
2022
October 11, 2022 Material Transfer and Research Agreement with University of Pittsburgh (portions of this agreement have been redacted in compliance with Regulation S-K Item...
HEMISPHERX BIOPHARMA INC
Biotechnology
2022
June 13, 2022 Amarex Work Order (portions of this Agreement have been redacted in compliance with Regulation S-K Item 601(b)(10))
HEMISPHERX BIOPHARMA INC
Biotechnology
2022
April 7, 2022 Amarex Work Order (portions of this Agreement have been redacted in compliance with Regulation S-K Item 601(b)(10))
HEMISPHERX BIOPHARMA INC
Biotechnology
2022
April 1, 2021 extension of April 1, 2020 Material Transfer and Research Agreement with Shenzhen Smoore Technology Limited
HEMISPHERX BIOPHARMA INC
Biotechnology
2021
May 21, 2021 extension of April 1, 2020 Material Transfer and Research Agreement with Shenzhen Smoore Technology Limited
HEMISPHERX BIOPHARMA INC
Biotechnology
2021
Material Transfer And Research Agreement with the University of Cagliari Dipartimento di Scienze della Vita e dellAmbiente executed on April 5, 2021 (Portions of this Agreement...
HEMISPHERX BIOPHARMA INC
Biotechnology
FL
2021
May 1, 2021 extension of April 1, 2020 Material Transfer and Research Agreement with Shenzhen Smoore Technology Limited
HEMISPHERX BIOPHARMA INC
Biotechnology
2021
Material Transfer and Research agreement with Roswell Park Comprehensive Cancer Center executed on April 14, 2021 (Portions of this Agreement have been redacted in compliance with...
HEMISPHERX BIOPHARMA INC
Biotechnology
NY
2021
December 30, 2020 Amendment to Project Work Order with Amarex Clinical Research LLC. (Portions of this Agreement have been redacted in compliance with Regulation S-K Item...
HEMISPHERX BIOPHARMA INC
Biotechnology
2021
November 29, 2020, Material Transfer and Research Agreement with Leyden Laboratories, B.V. (Portions of this Agreement have been redacted in compliance with Regulation S-K Item...
HEMISPHERX BIOPHARMA INC
Biotechnology
FL
2021
January 11, 2021 Sponsor Agreement with Centre for Human Drug Research. (Portions of this Agreement have been redacted in compliance with Regulation S-K Item 601(b)(10))
HEMISPHERX BIOPHARMA INC
Biotechnology
DE
2021
August 6, 2020, Project Work Order with Amarex Clinical Research LLC. (Portions of this Agreement have been redacted in compliance with Regulation S-K Item 601(b)(10))
HEMISPHERX BIOPHARMA INC
Biotechnology
2020
July 6, 2020, Clinical Trial Agreement with Roswell Park Comprehensive Cancer Center. (Portions of this Agreement have been redacted in compliance with Regulation S-K Item...
HEMISPHERX BIOPHARMA INC
Biotechnology
NY
2020
July 1, 2020, Material Transfer and Research Agreement with the Japanese National Institute of Infectious Diseases and Shionogi & Co., Ltd. (Portions of this Agreement have been...
HEMISPHERX BIOPHARMA INC
Biotechnology
NY
2020
June 1, 2020, Material Transfer and Research Agreement with the University of Rochester. (Portions of this Agreement have been redacted in compliance with Regulation S-K Item...
HEMISPHERX BIOPHARMA INC
Biotechnology
NY
2020
April 1, 2020 Material Transfer and Research Agreement with Shenzhen Smoore Technology Limited
HEMISPHERX BIOPHARMA INC
Biotechnology
NY
2020
Amendment to 2017 Material Transfer and Research Agreement with Roswell Park Cancer Institute
HEMISPHERX BIOPHARMA INC
Biotechnology
NY
2020
Form of Agreement between the Company and the Warrantholders
HEMISPHERX BIOPHARMA INC
Biotechnology
2019
Form of Dealer - Manager Agreement
HEMISPHERX BIOPHARMA INC
Biotechnology
NY
2019
October 9, 2018, Restated Bill of Sale for the Restated First Amendment and Sale Agreement
HEMISPHERX BIOPHARMA INC
Biotechnology
2018
October 9, 2018, Clinical Trial Agreement with Roswell Park Comprehensive Cancer Center
HEMISPHERX BIOPHARMA INC
Biotechnology
NY
2018
March 26, 2018 Amendment No. 4 to Amended and Restated Early Access Agreement with Impatients N.V
HEMISPHERX BIOPHARMA INC
Biotechnology
2018
February 14, 2018 Amendment No. 3 to Amended and Restated Early Access Agreement with Impatients N.V
HEMISPHERX BIOPHARMA INC
Biotechnology
2018
June 28, 2017 Amendment No. 2 to Amended and Restated Early Access Agreement with Impatients N.V
HEMISPHERX BIOPHARMA INC
Biotechnology
2018
December 13, 2016 Amendment No. 1 to Amended and Restated Early Access Agreement with Impatients N.V
HEMISPHERX BIOPHARMA INC
Biotechnology
DE
2018
Engagement Letter, dated as of March 21, 2018 by and between Hemispherx Biopharma, Inc. and Ascendiant Capital Markets LLC
HEMISPHERX BIOPHARMA INC
Biotechnology
2018
AnnexA
HEMISPHERX BIOPHARMA INC
Biotechnology
2017
PROMISSORYNOTE
HEMISPHERX BIOPHARMA INC
Biotechnology
NJ
2017
AMENDEDAND RESTATED EARLY ACCESS AGREEMENT
HEMISPHERX BIOPHARMA INC
Biotechnology
2017
SECURITIESPURCHASE AGREEMENT
HEMISPHERX BIOPHARMA INC
Biotechnology
NY
2017
AMENDED AND RESTATED EARLY ACCESS AGREEMENT
HEMISPHERX BIOPHARMA INC
Biotechnology
2017
SECURITIESPURCHASE AGREEMENT
HEMISPHERX BIOPHARMA INC
Biotechnology
NY
2016